<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        27-370-06
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2006
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        PANTOMAX 40MG E.C.TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        PANTOPRAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        40
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Gastro-resistant coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        15
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        31.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            SAJA-SAUDI ARABIAN JAPANESE PHARMACEUTICAL CO
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Pantomax is a selective &ldquo;proton pump inhibitor&rdquo;, a medicine which<br />reduces the amount of acid produced in your stomach. It is used for<br />treating acid-related diseases of the stomach and intestine.<br /><strong>Pantomax is used to treat :<br />Adults and adolescents 12 years of age and above:</strong><br />- Reflux oesophagitis. An inflammation of your oesophagus (the tube<br />which connects your throat to your stomach) accompanied by the<br />regurgitation of stomach acid.<br />- An infection with a bacterium called Helicobacter pylori in patients<br />with duodenal ulcers and stomach ulcers in combination with two<br />antibiotics (Eradication therapy). The aim is to get rid of the bacteria<br />and so reduce the likelihood of these ulcers returning.<br />- Stomach and duodenal ulcers.<br />- Zollinger-Ellison-Syndrome and other conditions producing too<br />much acid in the stomach.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Pantomax&reg;</strong><br />- If you are allergic (hypersensitive) to Pantoprazole or to any of the<br />other ingredients of Pantomax (see section 6).<br />- If you are allergic to medicines containing other proton pump<br />inhibitors.<br /><strong>Take special care with Pantomax&reg;</strong><br />- If you have severe liver problems. Please tell your doctor if you have<br />ever had problems with your liver. He will check your liver enzymes<br />more frequently, especially when you are taking Pantomax as a longterm treatment. In the case of a rise of liver enzymes the treatment<br />should be stopped.<br />- If you need to take medicines called NSAIDs continuously and receive<br />Pantomax because you have an increased risk of developing stomach<br />and intestinal complications. Any increased risk will be assessed<br />according to your own personal risk factors such as your age (65 years<br />old or more), a history of stomach or duodenal ulcers or of stomach or<br />intestinal bleeding.<br />- If you have reduced body stores or risk factors for reduced vitamin<br />B12 and receive long-term treatment with Pantoprazole. As with all<br />acid reducing agents, Pantoprazole may lead to a reduced absorption<br />of vitamin B12.<br />- If you are taking a medicine containing Atazanavir (for the treatment<br />of HIV-infection) at the same time as Pantoprazole, ask your doctor for<br />specific advice.<br /><strong>Tell your doctor immediately </strong>if you notice any of the following<br />symptoms:<br />- An unintentional loss of weight<br />- repeated vomiting<br />- Difficulty in swallowing<br />- vomiting blood<br />- You look pale and feel weak (Anaemia)<br />- You notice blood in your stools<br />- Severe and/or persistent diarrhoea, as Pantomax has been<br />associated with a small increase in infectious diarrhoea.<br />Your doctor may decide that you need some tests to rule out malignant<br />disease because Pantoprazole also alleviates the symptoms of cancer<br />and could cause delay in diagnosing it. If your symptoms continue in<br />spite of your treatment, further investigations will be considered.<br />If you take Pantomax on a long-term basis (longer than 1 year) your<br />doctor will probably keep you under regular surveillance. You should<br />report any new and exceptional symptoms and circumstances<br />whenever you see your doctor.<br /><strong>Taking other medicines</strong><br />Pantomax may influence the effectiveness of other medicines, so tell<br />your doctor if you are taking<br />- Medicines such as Ketoconazole, Itraconazole and Posaconazole<br />(used to treat fungal infections) or Erlotinib (used for certain types of<br />cancer) because Pantomax may stop these and other medicines from<br />working properly.<br />- Warfarin and Phenprocoumon, which affect the thickening, or<br />thinning of the blood. You may need further checks.<br />- Atazanavir (used to treat HIV-infection).<br />Please tell your doctor or pharmacist if you are taking or have recently<br />taken any other medicines, including medicines obtained without a<br />prescription.<br /><strong>Pregnancy and breast-feeding</strong><br />There are no adequate data from the use of Pantoprazole in pregnant<br />women. Excretion into human milk has been reported. If you are<br />pregnant, or think you may be pregnant, or if you are breast-feeding,<br />you should use this medicine, only if your doctor considers the benefit<br />for you greater than the potential risk for your unborn child or baby.<br /><strong>Ask your doctor or pharmacist for advice before taking any<br />medicine.<br />Driving and using machines</strong><br />If you experience side effects like dizziness or disturbed vision, you<br />should not drive or operate machines</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Pantomax exactly as your doctor has told you. You should<br />check with your doctor or pharmacist if you are not sure.<br /><strong>When and how should you take Pantomax?</strong><br />Take the tablets 1 hour before a meal without chewing or breaking them<br />and swallow them whole with some water. Unless told otherwise by your<br />doctor<br /><strong>For Adults and adolescents 12 years of age and above to treat reflux<br />oesophagitis</strong><br />The usual dose is one tablet a day. Your doctor may tell you to increase<br />to 2 tablets daily. The treatment period for reflux oesophagitis is usually<br />between 4 and 8 weeks. Your doctor will tell you how long to take your<br />medicine.<br /><strong>Adults:</strong><br />- <strong>For the treatment of an infection with a bacterium called<br />Helicobacter pylori in patients with duodenal ulcers and<br />stomach ulcers in combination with two antibiotics (Eradication<br />therapy).</strong><br />One tablet, two times a day plus two antibiotic tablets of either<br />Amoxicillin, Clarithromycin and Metronidazole (or Tinidazole), each to<br />be taken two times a day with your Pantoprazole tablet. Take the first<br />Pantoprazole tablet 1 hour before breakfast and the second Pantoprazole<br />tablet 1 hour before your evening meal. Follow your doctor&#39;s instructions<br />and make sure you read the package leaflets for these antibiotics. The<br />usual treatment period is one to two weeks.<br />- <strong>For the treatment of stomach and duodenal ulcers.</strong><br />The usual dose is one tablet a day. After consultation with your doctor,<br />the dose may be doubled. Your doctor will tell you how long to take your<br />medicine. The treatment period for stomach ulcers is usually between<br />4 and 8 weeks. The treatment period for duodenal ulcers is usually<br />between 2 and 4 weeks.<br />- <strong>For the long-term treatment of Zollinger-Ellison-Syndrome and<br />of other conditions in which too much stomach acid is produced.</strong><br />The recommended starting dose is usually two tablets a day.<br />Take the two tablets 1 hour before a meal. Your doctor may later adjust<br />the dose, depending on the amount of stomach acid you produce. If<br />prescribed more than two tablets a day, the tablets should be taken<br />twice daily.<br />If your doctor prescribes a daily dose of more than four tablets a day, you<br />will be told exactly when to stop taking the medicine.<br /><strong>Special patient groups:</strong><br />-If you have kidney problems, moderate or severe liver problems, you<br />should not take Pantomax for eradication of Helicobacter pylori.<br />-If you suffer from severe liver problems, you should not take more<br />than one tablet 20 mg Pantoprazole a day (for this purpose tablets<br />containing 20 mg Pantoprazole are available).<br /><strong>Children below 12 years.</strong><br />These tablets are not recommended for use in children below 12 years.<br /><strong>If you take more Pantomax than you should</strong><br />Tell your doctor or pharmacist. There are no known symptoms of<br />overdose.<br /><strong>If you forget to take Pantomax</strong><br />Do not take a double dose to make up for the forgotten dose. Take your<br />next normal dose at the usual time.<br /><strong>If you stop taking Pantomax</strong><br />Do not stop taking these tablets without first talking to your doctor or<br />pharmacist.<br />If you have any further questions about the use of this product, ask your<br />doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Pantomax can cause side effects, although not<br />everybody gets them.<br />The frequency of possible side effects listed below is defined using the<br />following convention:<br />very common (affects more than 1 user in 10)<br />common (affects 1 to 10 users in 100)<br />uncommon (affects 1 to 10 users in 1,000)<br />rare (affects 1 to 10 users in 10,000)<br />very rare (affects less than 1 user in 10,000)<br />not known (frequency cannot be estimated from the available data)<br /><strong>If you get any of the following side effects, stop taking these<br />tablets and tell your doctor immediately, or contact the casualty<br />department at your nearest hospital:</strong><br />- <strong>Serious allergic reactions (frequency rare): </strong>swelling of the tongue<br />and/or throat, difficulty in swallowing, hives (nettle rash), difficulties<br />in breathing, allergic facial swelling (Quincke&#39;s oedema / angioedema),<br />severe dizziness with very fast heartbeat and heavy sweating.<br />- <strong>Serious skin conditions (frequency not known): </strong>blistering of<br />the skin and rapid deterioration of your general condition, erosion<br />(including slight bleeding) of eyes, nose, mouth/lips or genitals<br />(Stevens-Johnson-Syndrome, Lyell-Syndrome, Erythema multiforme),<br />and sensitivity to light.<br />- Other serious conditions (frequency not known): yellowing of the<br />skin or whites of the eyes (severe damage to liver cells, jaundice) or<br />fever, rash, and enlarged kidneys sometimes with painful urination,<br />and lower back pain (serious inflammation of the kidneys).<br />Other side effects are:<br />- <strong>Uncommon </strong>(affects 1 to 10 users in 1,000)<br />headache, dizziness, diarrhoea, feeling sick, vomiting, bloating and<br />flatulence (wind), constipation, dry mouth, abdominal pain and<br />discomfort, skin rash, exanthema, eruption, itching, feeling weak,<br />exhausted or generally unwell, sleep disorders.<br />Taking a proton pump inhibitor like Pantoprazole, especially over a<br />period of more than one year, may slightly increase your risk of fracture in<br />the hip, wrist or spine. Tell your doctor if you have osteoporosis or if you<br />are taking corticosteroids (which can increase the risk of osteoporosis).<br />- <strong>Rare </strong>(affects 1 to 10 users in 10,000)<br />distortion or complete lack of the sense of taste, disturbances in vision<br />such as blurred vision, hives, pain in the joints, muscle pains, weight<br />changes, raised body temperature, high fever, swelling of the extremities<br />(peripheral oedema), allergic reactions, depression, breast enlargement<br />in males.<br />- <strong>Very Rare </strong>(affects less than 1 user in 10,000) disorientation.<br />- <strong>Not known </strong>(frequency cannot be estimated from the available data)<br />Hallucination, confusion (especially in patients with a history of these<br />symptoms), decreased sodium level in blood. If you are on Pantomax<br />for more than three months it is possible that the levels of magnesium<br />in your blood may fall. Low levels of magnesium can be seen as<br />fatigue, involuntary muscle contractions, disorientation, convulsions,<br />dizziness, increased heart rate. If you get any of these symptoms,<br />please tell your doctor promptly. Low levels of magnesium can also<br />lead to a reduction in potassium or calcium levels in the blood. Your<br />doctor may decide to perform regular blood tests to monitor your<br />levels of magnesium.<br /><strong>Side effects identified through blood tests:</strong><br />- <strong>Uncommon </strong>(affects 1 to 10 users in 1,000) an increase in liver<br />enz ymes.<br />- <strong>Rare </strong>(affects 1 to 10 users in 10,000)<br />an increase in bilirubin, increased fat levels in blood, sharp drop in<br />circulating granular white blood cells, associated with high fever.<br />- <strong>Very Rare </strong>(affects less than 1 user in 10,000) a reduction in the number<br />of blood platelets, which may cause you to bleed or bruise more than<br />normal, a reduction in the number of white blood cells, which may<br />lead to more frequent infections, coexisting abnormal reduction in the<br />number of red and white blood cells, as well as platelets.<br />If any of the side effects gets serious, or if you notice any side effects not<br />listed in this leaflet, please tell your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Store below 30&quot;C.<br />Do not use Pantomax&reg;, after the expiry date which is stated on the<br />blister and carton after EXP.<br />The expiry date refers to the last day of that month.<br />Medicines should not be disposed of via wastewater or household<br />waste. Ask your pharmacist how to dispose of medicines no longer<br />required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>The active substance is </strong>Pantoprazole. Each gastro-resistant tablet<br />contains 40 mg of pantoprazole (as sodium sesquihydrate).<br /><strong>The other ingredients are:</strong><br />Sodium carbonate (anhydrous), mannitol, crospovidone, calcium<br />stearate, hypromellose, Opadry white, Acryl Eze Yellow<br /><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Oblong, Yellow biconvex enteric coated tablet.
Pantomax supplied as blister (ALU/ALU blister) Packs with 15 or 30
enteric coated tablet.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>SAJA Pharmaceuticals<br />Saudi Arabian Japanese pharmaceutical company limited<br />Jeddah - Saudi Arabia</p><p><strong>-To report any side effect(s):<br />&bull; Saudi Arabia</strong><br />- The National Pharmacovigilance Centre (NPC):<br />- SFDA Call Center: 19999<br />- E-mail: npc.drug@sfda.gov.sa<br />- Website: https://ade.sfda.gov.sa<br /><strong>&bull; Other GCC states /other countries</strong><br />-Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                March/2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">بانتوماكس هو مثبط لمضخة البروتون، و هو دواء يقلل من كمية الأحماض التي يتم إفرازها في المعدة. يُستخدم بانتوماكس لعلاج الأمراض المتعلقة بأحماض المعدة والأمعاء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يستخدم بانتوماكس في علاج:</strong></p><p dir="RTL"><strong>البالغون والمراهقون ممن تزيد أعمارهم عن 12 سنة لعلاج:</strong></p><p dir="RTL">التهاب المريء الارتجاعي: هو التهاب المريء (الأنبوب الذي يربط بين الحلق والمعدة) المصحوب بارتجاع أحماض المعدة.</p><p dir="RTL">عدوى بكتريا تُسمى المَلَوِيُّة البَوّابية في المرضى المصابين بقُرح الاثنا عشر وقرح المعدة بالتناول المتزامن مع اثنين من المضادات الحيوية (علاج للقضاء على البكتريا). الهدف من ذلك هو التخلص من البكتريا وكذلك الحد من احتمالية عودة هذه القُرح.</p><p dir="RTL">قُرح المعدة والاثنا عشر.</p><p dir="RTL">متلازمة زولينجَر إيليسون والحالات الأخرى التي تتسبب في إفراز كمية كبيرة جدًا من الأحماض في المعدة&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول بانتوماكس</strong></p><p dir="RTL">إذا كنت تعاني من حساسية (فرط الحساسية) تجاه باننتوبرازول أو ايِ من المكونات الأخرى لبانتوماكس (انظر القسم 6 ).</p><p dir="RTL">إذا كنت تعاني من حساسية تجاه أدوية تحتوي على مثبطات أخرى لمضخة البروتون.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>توخَ حذرًا خاصًا مع بانتوماكس</strong>&nbsp;</p><p dir="RTL">إذا كان لديك مشاكل شديدة في الكبد. يُرجى إخبار طبيبك إذا كنت قد عانيت من قبل من مشاكل في الكبد. سيفحص طبيبك إنزيمات الكبد لديك بشكل أكثر تكرارًا، خاصًة عند تناولك بانتوماكس كعلاج طويل المدى. يجب وقف العلاج في حالة ارتفاع مستويات إنزيمات الكبد.</p><p dir="RTL">إذا كنت بحاجة لتناول أدوية تُسمى مضادات الالتهاب غير الستيرويدية (NSAIDs) بشكل مستمر وتتناول بانتوماكس فإن ذلك قد يزيد من مخاطر حدوث مضاعفات المعدة والأمعاء. سيتم تقييم أي مخاطر متزايدة وفقًا لعوامل الخطر الخاصة بك مثل عُمرك (65 سنة أو أكثر)، وجود تاريخ مرضي من قُرح المعدة والاثنا عشر أو نزيف بالمعدة أو الأمعاء.</p><p dir="RTL">إذا كانت مخزونات الجسم لديك منخفضة أو لديك عوامل خطر لانخفاض مستويات فيتامين ب12 و تتلقى علاجًا طويل المدى باستخدام بانتوبرازول. كما هو الحال مع جميع الأدوية الخافضة للأحماض، قد يؤدي بانتوبرازول إلى امتصاص فيتامين ب12.</p><p dir="RTL">إذا كنت تتناول دواًء يحتوي على اتازانافير (لعلاج عدوى فيروس نقص المناعة البشرية &quot; الايدز &ldquo;) بالتزامن مع بانتوبرازول، فاستشر طبيبك للحصول على المشورة الدقيقة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أبلغ طبيبك على الفور</strong>&nbsp;إذا لاحظت أيٍ من الأعراض الآتية:</p><p dir="RTL">فقدان وزن غير متعمد&nbsp;</p><p dir="RTL">قيء متكرر</p><p dir="RTL">صعوبة في البلع&nbsp;</p><p dir="RTL">قيء دموي (قيء مصحوب بدم)</p><p dir="RTL">الشحوب والشعور بالضعف (فقر الدم)</p><p dir="RTL">ملاحظة وجود دم لديك في البراز&nbsp;</p><p dir="RTL">إسهال شديد و/ أو مستمر، حيث يصاحب بانتوماكس زيادة محدودة في الإصابة بالإسهال المُعدي.</p><p dir="RTL">قد يقرر طبيبك أنك تحتاج إلى بعض الفحوصات لاستبعاد وجود ورم خبيث ذلك لان بانتوبرازول يحد أيضًا من أعراض السرطان وقد يؤدي إلى تأخير تشخيصه. إذا استمرت الأعراض لديك على الرغم من العلاج، فسيتم النظر في اجراء بعض الفحوصات الأخرى.</p><p dir="RTL">إذا كنت تتناول بانتوماكس على المدى الطويل (لأكثر من عام) فمن المحتمل أن يقوم طبيبك بإخضاعك لمراقبة منتظمة. يجب عليك الإبلاغ عن أي أعراض أو ظروف جديدة واستثنائية عند رؤيتك لطبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول أدوية أخرى</strong></p><p dir="RTL">قد يؤثر بانتوماكس على فعالية الأدوية الأخرى، لذلك أبلغ طبيبك إذا كنت تتناول:</p><p dir="RTL">أدوية مثل كيتوكونازول، وايتراكونازول، وبوساكونازول (تُستخدم لعلاج العدوى الفطرية) أو إرلوتينيب (يُستخدم لعلاج بعض أنواع السرطان) حيث قد يوقف بانتوماكس هذه الأدوية وأدوية أخرى عن العمل بشكل مناسب.</p><p dir="RTL">وارفارين وفينبروكومون، اللذان يؤثران على زيادة لزوجة، أو سيولة الدم. لذلك قد تحتاج لبعض الفحوصات الإضافية.</p><p dir="RTL">أتازانافير (يُستخدم لعلاج عدوى فيروس نقص المناعة البشرية &quot; الايدز&ldquo;).</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُرجى إبلاغ الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أية أدوية أخرى، بما فيها الأدوية التي حصلت عليها دون وصفة طبية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">لا توجد بيانات كافية عن استخدام بانتوبرازول في النساء الحوامل. تم الإبلاغ عن إفراز بانتوبرازول في لبن الأم، إذا كنتِ حاملًا أو تظنين أنكِ حاملًا، أو كنت ترضعين،&nbsp; فيجب عليكِ استخدام هذا الدواء فقط إذا كان طبيبك يرى أن الفائدة التي ستعود&nbsp; عليكِ من هذا الدواء أكبر من المخاطر المحتملة التي قد يتعرض لها جنينك أو طفلك.</p><p dir="RTL"><br /><strong>استشيري الطبيب أو الصيدلي الخاص بكِ قبل تناوُل أي دواء&nbsp;</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">إذا عانيت من أعراض جانبية مثل الدوخة أو عدم وضوح الرؤية، فيجب عليك الامتناع عن القيادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول بانتوماكس دائمًا كما أخبرك طبيبك بالضبط. إذا لم تكن متأكدًا، فيجب عليك مراجعة الطبيب أو الصيدلي الخاص بك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">متى<strong>&nbsp;وكيف يجب تناول بانتوماكس</strong></p><p dir="RTL">تناول الأقراص قبل ساعة واحدة من الوجبة ولا تمضغها أو تكسرها وابتلعها كاملةً مع بعض الماء. ما لم يُخبرك طبيبك بخلاف ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">للبالغين<strong>&nbsp;والمراهقون ممن تزيد أعمارهم عن 12 سنة لعلاج التهاب المريء الارتجاعي&nbsp;</strong></p><p dir="RTL">الجرعة المعتادة هي قرص واحد في اليوم. قد يخبرك طبيبك بزيادة الجرعة إلى قرصين يوميًا. عادة ما تكون فترة العلاج من التهاب المريء الارتجاعي بين 4 و8 أسابيع. سيخبرك طبيبك بالمدة اللازمة لتناوُل الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>البالغون:</strong></p><p dir="RTL"><strong>للعلاج من عدوى بكتريا تُسمى المَلْويَة البَوَابية في المرضى الذين يُعانون من قُرح الاثنا عشر والمعدة بالتزامن مع اثنين من المضادات الحيوية (علاج للقضاء على البكتريا)</strong></p><p dir="RTL">قرص واحد مرتين في اليوم مع قرصين من المضاد الحيوي إما اموكسيسيللن وكلاريثرومايسين ومترونيدازول (أو تينيدازول)، على أن يتم تناول كل منهما مرتين في اليوم مع قرص بانتوبرازول. تناول القرض الأول من بانتوبرازول قبل ساعة واحدة من الإفطار والقرص الثاني قبل ساعة واحدة من وجبتك المسائية.&nbsp;</p><p dir="RTL">اتبع تعليمات طبيبك وتأكد من قراءة نشرات العبوة لهذه المضادات الحيوية. الفترة المعتادة للعلاج هي من أسبوع إلى أسبوعين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لعلاج قُرح المعدة والإثنا عشر.</strong></p><p dir="RTL">الجرعة المعتادة هي قرص واحد في اليوم. قد يتم مضاعفة الجرعة، بعد استشارة طبيبك. سيخبرك طبيبك بالمدة اللازمة لتناول الدواء. عادة ما تكون فترة العلاج من قُرح المعدة&nbsp; بين 4 و8 أسابيع. عادة ما تكون فترة العلاج من قُرح الإثنا عشر بين أسبوعين و4 أسابيع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>للعلاج طويل المدى من متلازمة زولينجَر غيليسون والحالات الأخرى التي تسبب إفراز كمية كبيرة جدًا من الأحماض في المعدة.</strong></p><p dir="RTL">جرعة البدء الموصى بها عادة قرصين في اليوم تناول القرصين قبل ساعة واحدة من الوجبة. قد يعدل طبيبك الجرعة فيما بعد، حسب كمية الأحماض التي تفرزها معدتك. إذا تم وصف أكثر من قرصين في اليوم. فيجب تناول الأقراص مرتين في اليوم.</p><p dir="RTL">إذا وصف لك طبيبك جرعة يومية أكثر من أربعة أقراص في اليوم، فسيتم أخبارك بالموعد المحدد لوقف تناول الدواء.</p><p dir="RTL"><br /><strong>مجموعات خاصة من المرضى:</strong></p><p dir="RTL"><strong>إذا</strong>&nbsp;كنت تعاني من مشاكل في الكلى، أو أي مشاكل معتدلة إلى شديدة في الكبد فيجب ألا تتناول بانتوماكس للقضاء على بكتريا المَلَوِيّة البوّابية.</p><p dir="RTL">إذا كنت تعاني من مشاكل شديدة في الكبد، فيجب عليك عدم تناول أكثر من قرص واحد من بانتوبرازول 20 ملج في اليوم (لهذا السبب تتوافر اقراص تحتوي على 20 ملج بانتوبرازول).</p><p dir="RTL">الأطفال الأقل من 12 سنة: لا يُوصى باستخدام هذه الأقراص في الأطفال أقل من 12 سنة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا تناولت كمية من بانتوماكس أكثر مما يجب</strong>&nbsp;</p><p dir="RTL">أخبر الطبيب أو الصيدلي الخاص بك. ليس هناك أعراض معروفة للجرعة الزائدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا نسيت تناوُل بانتوماكس</strong>&nbsp;</p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها.&nbsp;</p><p dir="RTL">تناول فقط جرعتك التالية في الوقت المعتاد.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا توقفت عن تناول بانتوماكس</strong></p><p dir="RTL">لا تتوقف عن تناول هذه الأقراص دون التحدث إلى الطبيب أو الصيدلي الخاص بك أولًا.</p><p dir="RTL">إذا كانت لديك أسئلة إضافية حول استخدام هذا الدواء، فاستشر الطبيب أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب بانتوماكس أعرضا جانبية، على الرغم من أنها لا تحدث لدى الجميع .</p><p dir="RTL">فيما يلي تعريف لمعدلات تكرار الأعراض الجانبية المحتملة المدرجة أدناه :</p><p dir="RTL">شائعة جدًا (تؤثر على أكثر من 1 من كل 10 مستخدمين)&nbsp;</p><p dir="RTL">شائعة (تؤثر على من 1 إلى 10 من كل 100 مستخدم)</p><p dir="RTL">غير شائعة ( تؤثر على من 1 إلى 10 من كل 1000 مستخدم)</p><p dir="RTL">نادرة (تؤثر على من 1 إلى 10 من كل 10000 مستخدم)</p><p dir="RTL">نادرة جدًا (تؤثر على&nbsp; أقل من 1 من كل 10000 مستخدم)</p><p dir="RTL">غير معروفة (لا يمكن تقدير معدل تكرارها من واقع البيانات المتاحة)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا عانيت من أي الأعراض الجانبية الآتية، فتوقف عن تناول هذه الأقراص و أخبر طبيبك على الفور، اتصل بقسم الطوارئ في أقرب مستشفى إليك :</strong></p><p dir="RTL"><strong>تفاعلات حساسية خطيرة</strong>&nbsp;(نادرة التكرار): تَوَرُم اللسان و \ أو الحلق، وصعوبة في البلع، وشري (طفح القراص)، وصعوبات في التنفس، وتَوَرُم الوجه التحسسي (وذمة كونيك \ وذمة وعائية)، ودوخة شديدة مع ضربات قلب سريعة جدًا وتعرق شديد.</p><p dir="RTL"><strong>الحالات الجلدية الخطيرة</strong>&nbsp;(معدل التكرار غير معروف): تقرُح الجلد والتدهور السريع لحالتك العامة.</p><p dir="RTL">وتآكل \ قرح (يشمل نزيفًا بسيطًا) في العينين، أو الأنف، أو الفم \ الشفتين أو الأعضاء التناسلية (متلازمة ستيفنز جونسون، متلازمة لايل، احمرار متعدد الأشكال)، وحساسية تجاه الضوء.</p><p dir="RTL"><strong>حالات خطيرة أخرى</strong>&nbsp;(معدل التكرار غير معروف): اصفرار الجلد أو بياض العينين (تلف شديد لخلايا الكبد، اليرقان &quot; الصفراء &ldquo;) أو حُمى، وطفح جلدي، وتضخم الكُلى مع ألم عند التبول أحيانًا، وألم أسفل الظهر (التهاب كلوي خطير).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أعراض جانبية أخرى:</strong></p><p dir="RTL"><strong>غير شائعة</strong>&nbsp;(تؤثر على من 1 إلى 10 من كل 1000 مستخدم)&nbsp;</p><p dir="RTL">صداع، ودوخة، وإسهال، وشعور بالمرض، وقيء، وانتفاخ المعدة وريح، وإمساك، وجفاف الفم، وألم وعدم راحة بالبطن، وطفح جلدي. وطفح ظاهر، وحكة، وشعور بالضعف، وإنهاك أو شعور العام بعدم الراحة، واضطرابات النوم.</p><p dir="RTL">قد يؤدي تناوُل مثبط لمضخة البروتون مثل بانتوبرازول، خاصة لأكثر من عام، إلى زيادة طفيفة في مخاطر حدوث كسر في الفخذ أو المعصم أو العمود الفقري.&nbsp;</p><p dir="RTL">أخبر طبيبك إذا كنت تعاني من هشاشة في العظام أو إذا كنت تتناول الكورتيكوستيرويدات (التي من ممكن أن تُزيد من مخاطر حدوث هشاشة العظام).&nbsp;</p><p dir="RTL"><strong>نادرة</strong>&nbsp;(تؤثر على من 1 إلى 10 من كل10.000 مستخدم)&nbsp;</p><p dir="RTL">تغيرات أو فقد تام لحاسة التذوُق، واضطرابات في الرؤية، على سبيل المثال، رؤية مشوشة، شري (ارتكاريا)، وألم فب المفاصل، وآلام العضلات، وتغيرات الوزن، و ارتفاع درجة حرارة الجسم، وحمى مرتفعة، و توَرُم الأطراف (وذمة طرفية)، و تفاعلات حساسية، و اكتئاب، و تضخم الثدي لدي الرجال.</p><p dir="RTL"><strong>نادر جدًا</strong>&nbsp;(تؤثر على أقل من 1 من كل 10.000 مستخدم)&nbsp;</p><p dir="RTL">توهان.</p><p dir="RTL"><strong>غير معروفة</strong>&nbsp;(لا يمكن تقدير تكرار الأعراض الجانبية من واقع البيانات المتاحة) هلوسة، وارتباك (خاصًة في المرضى من لديهم تاريخ مرضي من هذه الاعراض)، وانخفاض مستويات الصوديوم في الدم. إذا كنت تتناول بانتوماكس لأكثر من ثلاثة أشهر فمن المحتمل هبوط مستويات الماغنسيوم لديك في الدم. يمكن ملاحظة انخفاض مستويات الماغنسيوم من خلال الشعور بالإجهاد، وتقلصات لا إرادية في العضلات، وتوهان، وتشنجات، ودوخة، وزيادة معدل ضربات القلب، إذا عانيت أيِ من هذه الأعراض، فيرجى إخبار طبيبك على الفور. قد تؤدي أيضًا المستويات المنخفضة من الماغنسيوم إلى انخفاض في مستويات البوتاسيوم أو الكالسيوم في الدم. قد يقرر طبيبك إجراء فحوصات دم منتظمة لمراقبة مستويات الماغنسيوم لديك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الأعراض الجانبية التي تم التعرف عليها من خلال فحوصات الدم:</p><p dir="RTL"><strong>غير شائعة</strong>&nbsp;(تؤثر على من 1 إلى 10 من كل 1000 مستخدم) زيادة مستويات إنزيمات الكبد. &nbsp;</p><p dir="RTL"><strong>نادرة</strong>&nbsp;(تؤثر على من 1 إلى 10 من كل 10000 مستخدم)&nbsp;</p><p dir="RTL">زيادة نسبة البِيليروبين، زيادة مستويات الدهون في الدم، انخفاض حاد في أحد أنواع خلايا الدم البيضاء تسمى الحُبيبية الجائلة، وما يصاحب ذلك من حمى مرتفعة.</p><p dir="RTL"><strong>نادرة جدًا</strong>&nbsp;(تؤثر على أقل من 1 من كل 10000 مستخدم) انخفاض في عدد الصفائح الدموية، قد يسبب الإصابة بنزيف أو كدمات بشكل أكثر من المعتاد. انخفاض في عدد خلايا الدم البيضاء، قد يؤدي إلى الإصابة بالعدوى بشكل أكثر تكرارًا، انخفاض مصاحب وغير طبيعي في عدد خلايا الدم الحمراء والبيضاء، كذلك عدد الصفائح الدموية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أصبح أيِ من الأعراض الجانبية خطيرًا، أو إذا لاحظت أي أعراض جانبية غير المدرجة في هذه النشرة، يُرجى إبلاغ الطبيب أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ بعيدًا عن متناول الأطفال&nbsp;</p><p dir="RTL">يُحفظ في درجة حرارة أقل من 30 درجة مئوية&nbsp;</p><p dir="RTL">لا يستخدم بانتوماكس بعد انتهاء تاريخ الصلاحية المدون على الشريط والعبوة الكرتونية بعد كلمة &quot; EXP &quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر&nbsp;</p><p dir="RTL">يجب عدم التخلص من الأدوية عن طريق مياه الصرف الصحي أو مع المخلفات المنزلية . اسأل الصيدلي الخاص بك عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها . ستساعد هذه الإجراءات في حماية البيئة .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي : بانتوبرازول. يحتوي كل قرص مقاوم للمعدة على ٤0 ملج بانتوبرازول (على هيئة صوديوم سيسكويهيدرات) .</p><p dir="RTL">المكونات الأخرى هي: كربونات صوديوم (لا مائية), مانيتول، وكروسبوفيدون, ستيرات كالسيوم, هايبروميلوز, أوبادراي ابيض, اكرايل ايز اصفر.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قرص اصفر, بيضاوي, ثنائي التحدب مُقاوم لإفرازات المعدة .</p><p dir="RTL">يتوفر بانتوماكس داخل شرائح من ألومنيوم, تحتوي كل عبوة على 15 أو 30 قرص مقاوم لإفرازات المعدة&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ساجا الصيدلانية</p><p dir="RTL">الشركة العربية السعودية اليابانية للمنتجات الصيدلانية المحدودة</p><p>جدة - المملكة العربية السعودية .</p><p>&nbsp;</p><p dir="RTL"><strong>للإبلاغ عن الأعراض الجانبية&nbsp;</strong></p><p dir="RTL"><strong>&bull; المملكة العربية السعودية</strong></p><p dir="RTL">- المركز الوطني للتيقظ والسلامة الدوائية&nbsp;</p><p dir="RTL">- مركز اتصالات الهيئة العامة للغذاء والدواء السعودية : 19999</p><p dir="RTL">- البريد الإلكتروني:&nbsp;npc.drug@sfda.gov.sa</p><p dir="RTL">- الموقع الإلكتروني:&nbsp;&nbsp;https://ade.sfda.gov.sa</p><p dir="RTL">&nbsp;</p><p dir="RTL">&bull;&nbsp;<strong>دول الخليج الأخرى/ الدول الأخرى</strong></p><p dir="RTL">- الرجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            مارس/ ٢٠٢٤
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Pantomax® 40mg gastro-resistant tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each gastro-resistant tablet contains 40mg pantoprazole (as sodium sesquihydrate).
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gastro-resistant tablet
Yellow, oval biconvex enteric-coated tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Moderate &amp; sever cases of inflammation of the esophagus (Reflux oesophagitis).<br />- Eradication of Helicobacter pylori (H. pylori) in combination with appropriate<br />antibiotic therapy in patients with H. pylori associated ulcers.<br />- Gastric and duodenal ulcer<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablets should not be chewed or crushed, and should be swallowed whole 1 hour before a<br />meal with some water.<br />Recommended dose<br />Reflux oesophagitis<br />One tablet of Pantomax per day. In individual cases the dose may be doubled (increase to 2<br />tablets Pantomax daily) especially when there has been no response to other treatment. A<br />4-week period is usually required for the treatment of reflux oesophagitis. If this is not<br />sufficient, healing will usually be achieved within a further 4 weeks.<br />Adults<br />Eradication of H. pylori in combination with two appropriate antibiotics<br />In H. pylori positive patients with gastric and duodenal ulcers, eradication of the germ by a<br />combination therapy should be achieved. Considerations should be given to official local<br />guidance (e.g. national recommendations) regarding bacterial resistance and the<br />appropriate use and prescription of antibacterial agents. Depending upon the resistance<br />pattern, the following combinations can be recommended for the eradication of H. pylori:<br />a) twice daily one tablet Pantomax<br />+ twice daily 1000 mg amoxicillin<br />+ twice daily 500 mg clarithromycin<br />b) twice daily one tablet Pantomax<br />+ twice daily 400 - 500 mg metronidazole (or 500 mg tinidazole)<br />+ twice daily 250 - 500 mg clarithromycin<br />c) twice daily one tablet Pantomax<br />+ twice daily 1000 mg amoxicillin<br />+ twice daily 400 - 500 mg metronidazole (or 500 mg tinidazole)<br />In combination therapy for eradication of H. pylori infection, the second Pantomax tablet<br />should be taken 1 hour before the evening meal. The combination therapy is implemented<br />for 7 days in general and can be prolonged for a further 7 days to a total duration of up to<br />two weeks. If, to ensure healing of the ulcers, further treatment with pantoprazole is<br />indicated, the dose recommendations for duodenal and gastric ulcers should be considered.<br />If combination therapy is not an option, e.g. if the patient has tested negative for H. pylori,<br />the following dose guidelines apply for Pantomax monotherapy:<br />Treatment of gastric ulcer<br />One tablet of Pantomax per day. In individual cases the dose may be doubled (increase to 2<br />tablets Pantomax daily) especially when there has been no response to other treatment. A<br />4-week period is usually required for the treatment of gastric ulcers. If this is not sufficient,<br />healing will usually be achieved within a further 4 weeks.<br />Treatment of duodenal ulcer<br />One tablet of Pantomax per day. In individual cases the dose may be doubled (increase to 2<br />tablets Pantomax daily) especially when there has been no response to other treatment. A<br />duodenal ulcer generally heals within 2 weeks. If a 2-week period of treatment is not<br />sufficient, healing will be achieved in almost all cases within a further 2 weeks.<br />Special populations<br />Children below 12 years of age<br />Pantomax is not recommended for use in children below 12 years of age due to limited data<br />on safety and efficacy in this age group.<br />Hepatic Impairment<br />A daily dose of 20 mg pantoprazole (1 tablet of 20 mg pantoprazole) should not be exceeded<br />in patients with severe liver impairment. Pantomax must not be used in combination<br />treatment for eradication of H. pylori in patients with moderate to severe hepatic<br />dysfunction since currently no data are available on the efficacy and safety of Pantomax in<br />combination treatment of these patients (see section 4.4).<br />Renal Impairment<br />No dose adjustment is necessary in patients with impaired renal function. Pantomax must<br />not be used in combination treatment for eradication of H. pylori in patients with impaired<br />renal function since currently no data are available on the efficacy and safety of Pantomax in<br />combination treatment for these patients.<br />Elderly<br />No dose adjustment is necessary in elderly patients.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, substituted benzimidazoles or to any of the
excipients.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Hepatic Impairment<br />In patients with severe liver impairment the liver enzymes should be monitored regularly<br />during treatment with pantoprazole, particularly on long-term use. In the case of a rise of<br />the liver enzymes the treatment should be discontinued (see section 4.2).<br />Co-administration with NSAIDs<br />The use of Pantomax 20 mg as a preventive of gastroduodenal ulcers induced by nonselective non-steroidal anti-inflammatory drugs (NSAIDs) should be restricted to patients<br />who require continued NSAID treatment and have an increased risk to develop<br />gastrointestinal complications. The increased risk should be assessed according to individual<br />risk factors, e.g. high age (&gt;65 years), history of gastric or duodenal ulcer or upper<br />gastrointestinal bleeding.<br />In presence of alarm symptoms<br />In the presence of any alarm symptom (e. g. significant unintentional weight loss, recurrent<br />vomiting, dysphagia, haematemesis, anaemia or melaena) and when gastric ulcer is<br />suspected or present, malignancy should be excluded, as treatment with pantoprazole may<br />alleviate symptoms and delay diagnosis.<br />Further investigation is to be considered if symptoms persist despite adequate treatment.<br />Co-administration with atazanavir<br />Co-administration of atazanavir with proton pump inhibitors is not recommended (see<br />section 4.5). If the combination of atazanavir with a proton pump inhibitor is judged<br />unavoidable, close clinical monitoring (e.g virus load) is recommended in combination with<br />an increase in the dose of atazanavir to 400 mg with 100 mg of ritonavir. A pantoprazole<br />dose of 20 mg per day should not be exceeded.<br />Influence on vitamin B12 absorption<br />Pantoprazole, as all acid-blocking medicines, may reduce the absorption of vitamin B12<br />(cyanocobalamin) due to hypo- or achlorhydria. This should be considered in patients with<br />reduced body stores or risk factors for reduced vitamin B12 absorption on long-term therapy<br />or if respective clinical symptoms are observed.<br />Long term treatment<br />In long-term treatment, especially when exceeding a treatment period of 1 year, patients<br />should be kept under regular surveillance.<br />Gastrointestinal infections caused by bacteria<br />Pantoprazole, like all proton pump inhibitors (PPIs), might be expected to increase the<br />counts of bacteria normally present in the upper gastrointestinal tract. Treatment with<br />Pantomax may lead to a slightly increased risk of gastrointestinal infections caused by<br />bacteria such as Salmonella and Campylobacter.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effect of pantoprazole on the absorption of other medicinal products<br />Because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may<br />reduce the absorption of drugs with a gastric pH dependent bioavailability, e.g some azole<br />antifungals as ketoconazole, itraconazole, posaconazole and other medicine as erlotinib.<br />HIV medications (atazanavir)<br />Co-administration of atazanavir and other HIV medications whose absorption is pHdependent with proton-pump inhibitors, might result in a substantial reduction in the<br />bioavailability of these HIV medications and might impact the efficacy of these medicines.<br />Therefore, the co-administration of proton pump inhibitors with atazanavir is not<br />recommended (see section 4.4).<br />Coumarin anticoagulants (phenprocoumon or warfarin)<br />Although no interaction during concomitant administration of phenprocoumon or warfarin<br />has been observed in clinical pharmacokinetic studies, a few isolated cases of changes in<br />International Normalised Ratio (INR) have been reported during concomitant treatment in<br />the post-marketing period. Therefore, in patients treated with coumarin anticoagulants (e.g.<br />phenprocoumon or warfarin), monitoring of prothrombin time / INR is recommended after<br />initiation, termination or during irregular use of pantoprazole.<br />Other interactions studies<br />Pantoprazole is extensively metabolized in the liver via the cytochrome P450 enzyme<br />system. The main metabolic pathway is demethylation by CYP2C19 and other metabolic<br />pathways include oxidation by CYP3A4.<br />Interaction studies with drugs also metabolized with these pathways, like carbamazepine,<br />diazepam, glibenclamide, nifedipine, and an oral contraceptive containing levonorgestrel<br />and ethinyl oestradiol, did not reveal clinically significant interactions.<br />Results from a range of interaction studies demonstrate that pantoprazole does not effect<br />the metabolism of active substances metabolised by CYP1A2 (such as caffeine, theophylline),<br />CYP2C9 (such as piroxicam, diclofenac, naproxen), CYP2D6 (such as metoprolol), CYP2E1<br />(such as ethanol), or does not interfere with p-glycoprotein related absorption of digoxin.<br />There were no interactions with concomitantly administered antacids.<br />Interaction studies have also been performed by concomitantly administering pantoprazole<br />with the respective antibiotics (clarithromycin, metronidazole, amoxicillin). No clinically<br />relevant interactions were found.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong><br />There are no adequate data from the use of pantoprazole in pregnant women. Studies in<br />animals have shown reproductive toxicity (see section 5.3). The potential risk for humans is<br />unknown. Pantomax should not be used during pregnancy, unless clearly necessary.<br /><strong>Lactation</strong><br />Animal studies have shown excretion of pantoprazole in breast milk. Excretion into human<br />milk has been reported. Therefore, a decision on whether to continue/discontinue breastfeeding or to continue/discontinue therapy with Pantomax should be made taking into<br />account the benefit of breast-feeding to the child, and the benefit of Pantomax therapy to<br />women.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions, such as dizziness and visual disturbances may occur (see section<br />4.8). If affected, patients should not drive or operate machines.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Approximately 5 % of patients can be expected to experience adverse drug reactions (ADRs).<br />The most commonly reported ADRs are diarrhoea and headache, both occurring in<br />approximately 1 % of patients.<br />The table below lists adverse reactions reported with pantoprazole, ranked under the<br />following frequency classification:<br />Very common ( 1/10); common ( 1/100 to &lt;1/10); uncommon ( 1/1,000 to &lt;1/100);<br />rare ( 1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000), not known (cannot be estimated from<br />the available data).<br />For all adverse reactions reported from post-marketing experience, it is not possible to apply<br />any Adverse Reaction frequency and therefore they are mentioned with a &ldquo;not known&rdquo;<br />frequency.<br />Within each frequency grouping, adverse reactions are presented in order of decreasing<br />seriousness.<br />Table 1. Adverse reactions with pantoprazole in clinical trials and post-marketing experience<br /><img src="data:image/png;base64,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" alt="" width="440" height="602" vspace="0" hspace="0" border="0" style="width:440px;height:602px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p><img src="data:image/png;base64,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" alt="" width="434" height="534" vspace="0" hspace="0" border="0" style="width:434px;height:534px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no known symptoms of overdose in man.<br />Systemic exposure with up to 240 mg administered intravenously over 2 minutes, were well<br />tolerated.<br />As pantoprazole is extensively protein bound, it is not readily dialysable.<br />In the case of an overdose with clinical signs of intoxication, apart from symptomatic and<br />supportive treatment, no specific therapeutic recommendations can be made.<br />&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Proton pump inhibitors, ATC code: A02BC02<br />Mechanism of action<br />Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid<br />in the stomach by specific blockade of the proton pumps of the parietal cells.<br />Pantoprazole is converted to its active form in the acidic environment in the parietal cells<br />where it inhibits the H+, K+-ATPase enzyme, i. e. the final stage in the production of<br />hydrochloric acid in the stomach. The inhibition is dose-dependent and affects both basal<br />and stimulated acid secretion. In most patients, freedom from symptoms is achieved within<br />2 weeks. As with other proton pump inhibitors and H2 receptor inhibitors, treatment with<br />pantoprazole reduces acidity in the stomach and thereby increases gastrin in proportion to<br />the reduction in acidity. The increase in gastrin is reversible. Since pantoprazole binds to the<br />enzyme distal to the cell receptor level, it can inhibit hydrochloric acid secretion<br />independently of stimulation by other substances (acetylcholine, histamine, gastrin). The<br />effect is the same whether the product is given orally or intravenously.<br />The fasting gastrin values increase under pantoprazole. On short-term use, in most cases<br />they do not exceed the upper limit of normal. During long-term treatment, gastrin levels<br />double in most cases. An excessive increase, however, occurs only in isolated cases. As a<br />result, a mild to moderate increase in the number of specific endocrine (ECL) cells in the<br />stomach is observed in a minority of cases during long-term treatment (simple to<br />adenomatoid hyperplasia). However, according to the studies conducted so far, the<br />formation of carcinoid precursors (atypical hyperplasia) or gastric carcinoids as were found<br />in animal experiments (see section 5.3) have not been observed in humans.<br />An influence of a long term treatment with pantoprazole exceeding one year cannot be<br />completely ruled out on endocrine parameters of the thyroid according to results in animal<br />studies.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Pantoprazole is rapidly absorbed and the maximal plasma concentration is achieved even<br />after one single 20 mg oral dose. On average at about 2.0 h - 2.5 h p.a. the maximum serum<br />concentrations of about 1-1.5 &micro;g/ml are achieved, and these values remain constant after<br />multiple administration. Pharmacokinetics does not vary after single or repeated<br />administration. In the dose range of 10 to 80 mg, the plasma kinetics of pantoprazole is<br />linear after both oral and intravenous administration.<br />The absolute bioavailability from the tablet was found to be about 77 %. Concomitant intake<br />of food had no influence on AUC, maximum serum concentration and thus bioavailability.<br />Only the variability of the lag-time will be increased by concomitant food intake.<br />Distribution<br />Pantoprazole&#39;s serum protein binding is about 98 %. Volume of distribution is about 0.15<br />l/kg.<br />Elimination<br />The substance is almost exclusively metabolized in the liver. The main metabolic pathway is<br />demethylation by CYP2C19 with subsequent sulphate conjugation, other metabolic pathway<br />includes oxidation by CYP3A4. Terminal half-life is about 1 hour and clearance is about 0.1<br />l/h/kg. There were a few cases of subjects with delayed elimination. Because of the specific<br />binding of pantoprazole to the proton pumps of the parietal cell the elimination half-life<br />does not correlate with the much longer duration of action (inhibition of acid secretion).<br />Renal elimination represents the major route of excretion (about 80 %) for the metabolites<br />of pantoprazole, the rest is excreted with the faeces. The main metabolite in both the serum<br />and urine is desmethylpantoprazole which is conjugated with sulphate. The half-life of the<br />main metabolite (about 1.5 hours) is not much longer than that of pantoprazole.<br />Characteristics in patients/special groups of subjects<br />Approximately 3 % of the European population lack a functional CYP2C19 enzyme and are<br />called poor metabolisers. In these individuals the metabolism of pantoprazole is probably<br />mainly catalysed by CYP3A4. After a single-dose administration of 40 mg pantoprazole, the<br />mean area under the plasma concentration-time curve was approximately 6 times higher in<br />poor metabolisers than in subjects having a functional CYP2C19 enzyme (extensive<br />metabolisers). Mean peak plasma concentrations were increased by about 60 %. These<br />findings have no implications for the posology of pantoprazole.<br />No dose reduction is recommended when pantoprazole is administered to patients with<br />impaired renal function (including dialysis patients). As with healthy subjects, pantoprazole&#39;s<br />half-life is short. Only very small amounts of pantoprazole are dialyzed. Although the main<br />metabolite has a moderately delayed half-life (2 - 3h), excretion is still rapid and thus<br />accumulation does not occur.<br />Although for patients with liver cirrhosis (classes A and B according to Child) the half-life<br />values increased to between 3 and 6 h and the AUC values increased by a factor of 3 - 5, the<br />maximum serum concentration only increased slightly by a factor of 1.3 compared with<br />healthy subjects.<br />A slight increase in AUC and Cmax in elderly volunteers compared with younger counterparts<br />is also not clinically relevant.<br />Children<br />Following administration of single oral doses of 20 or 40 mg pantoprazole to children aged 5<br />- 16 years AUC and Cmax were in the range of corresponding values in adults.<br />Following administration of single i.v. doses of 0.8 or 1.6 mg/kg pantoprazole to children<br />aged 2 - 16 years there was no significant association between pantoprazole clearance and<br />age or weight. AUC and volume of distribution were in accordance with data from adults.<br />Absorption<br />Pantoprazole is rapidly absorbed and the maximal plasma concentration is achieved even<br />after one single 20 mg oral dose. On average at about 2.0 h - 2.5 h p.a. the maximum serum<br />concentrations of about 1-1.5 &micro;g/ml are achieved, and these values remain constant after<br />multiple administration. Pharmacokinetics does not vary after single or repeated<br />administration. In the dose range of 10 to 80 mg, the plasma kinetics of pantoprazole is<br />linear after both oral and intravenous administration.<br />The absolute bioavailability from the tablet was found to be about 77 %. Concomitant intake<br />of food had no influence on AUC, maximum serum concentration and thus bioavailability.<br />Only the variability of the lag-time will be increased by concomitant food intake.<br />Distribution<br />Pantoprazole&#39;s serum protein binding is about 98 %. Volume of distribution is about 0.15<br />l/kg.<br />Elimination<br />The substance is almost exclusively metabolized in the liver. The main metabolic pathway is<br />demethylation by CYP2C19 with subsequent sulphate conjugation, other metabolic pathway<br />includes oxidation by CYP3A4. Terminal half-life is about 1 hour and clearance is about 0.1<br />l/h/kg. There were a few cases of subjects with delayed elimination. Because of the specific<br />binding of pantoprazole to the proton pumps of the parietal cell the elimination half-life<br />does not correlate with the much longer duration of action (inhibition of acid secretion).<br />Renal elimination represents the major route of excretion (about 80 %) for the metabolites<br />of pantoprazole, the rest is excreted with the faeces. The main metabolite in both the serum<br />and urine is desmethylpantoprazole which is conjugated with sulphate. The half-life of the<br />main metabolite (about 1.5 hours) is not much longer than that of pantoprazole.<br />Characteristics in patients/special groups of subjects<br />Approximately 3 % of the European population lack a functional CYP2C19 enzyme and are<br />called poor metabolisers. In these individuals the metabolism of pantoprazole is probably<br />mainly catalysed by CYP3A4. After a single-dose administration of 40 mg pantoprazole, the<br />mean area under the plasma concentration-time curve was approximately 6 times higher in<br />poor metabolisers than in subjects having a functional CYP2C19 enzyme (extensive<br />metabolisers). Mean peak plasma concentrations were increased by about 60 %. These<br />findings have no implications for the posology of pantoprazole.<br />No dose reduction is recommended when pantoprazole is administered to patients with<br />impaired renal function (including dialysis patients). As with healthy subjects, pantoprazole&#39;s<br />half-life is short. Only very small amounts of pantoprazole are dialyzed. Although the main<br />metabolite has a moderately delayed half-life (2 - 3h), excretion is still rapid and thus<br />accumulation does not occur.<br />Although for patients with liver cirrhosis (classes A and B according to Child) the half-life<br />values increased to between 3 and 6 h and the AUC values increased by a factor of 3 - 5, the<br />maximum serum concentration only increased slightly by a factor of 1.3 compared with<br />healthy subjects.<br />A slight increase in AUC and Cmax in elderly volunteers compared with younger counterparts<br />is also not clinically relevant.<br />Children<br />Following administration of single oral doses of 20 or 40 mg pantoprazole to children aged 5<br />- 16 years AUC and Cmax were in the range of corresponding values in adults.<br />Following administration of single i.v. doses of 0.8 or 1.6 mg/kg pantoprazole to children<br />aged 2 - 16 years there was no significant association between pantoprazole clearance and<br />age or weight. AUC and volume of distribution were in accordance with data from adults.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard to humans based on conventional studies of safety<br />pharmacology, repeated dose toxicity and genotoxicity.<br />In the two-year carcinogenicity studies in rats neuroendocrine neoplasms were found. In<br />addition, squamous cell papillomas were found in the forestomach of rats. The mechanism<br />leading to the formation of gastric carcinoids by substituted benzimidazoles has been<br />carefully investigated and allows the conclusion that it is a secondary reaction to the<br />massively elevated serum gastrin levels occurring in the rat during chronic high-dose<br />treatment. In the two-year rodent studies an increased number of liver tumors was<br />observed in rats and in female mice and was interpreted as being due to pantoprazole&#39;s high<br />metabolic rate in the liver.<br />A slight increase of neoplastic changes of the thyroid was observed in the group of rats<br />receiving the highest dose (200 mg/kg). The occurrence of these neoplasms is associated<br />with the pantoprazole-induced changes in the breakdown of thyroxine in the rat liver. As the<br />therapeutic dose in man is low, no harmful effects on the thyroid glands are expected.<br />In animal reproduction studies, signs of slight fetotoxicity were observed at doses above 5<br />mg/kg.<br />Investigations revealed no evidence of impaired fertility or teratogenic effects.<br />Penetration of the placenta was investigated in the rat and was found to increase with<br />advanced gestation. As a result, concentration of pantoprazole in the foetus is increased<br />shortly before birth.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mannitol , Crospovidone,Sodium Carbonate Anhydrous,Hyreromellose,Calcium Stearate,<br />Opadry,Acryl eze.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30&deg;C.<br />Store in the original package<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>How supplied<br />Packs of 15, 30 enteric coated tablets: Each enteric coated tablet contains Pantoprazole<br />Sodium Sesquihydrate equivalent to 40 mg Pantoprazole.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                SAJA Pharmaceuticals
Saudi Arabian Japanese pharmaceutical company limited
Jeddah – Saudi Arabia
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                July 2012
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>